Osaic Holdings’s Immix Biopharma IMMX Stock Holding History

Osaic Holdings’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.4K	Buy	+4,000	New	+$29.4K	﹤0.01%	5442
2024 Q4	–	Sell	-950	Closed	-$1.42K	–	7525
2024 Q3	$1.42K	Hold	950	–	–	﹤0.01%	6736
2024 Q2	$1.88K	Buy	+950	New	+$2.18K	﹤0.01%	6616
2024 Q1	–	Sell	-350	Closed	-$2.42K	–	7294
2023 Q4	$2.42K	Hold	350	–	–	﹤0.01%	6471
2023 Q3	$1.2K	Hold	350	–	–	﹤0.01%	6777
2023 Q2	$941	Hold	350	–	–	﹤0.01%	6890
2023 Q1	$637	Hold	350	–	–	﹤0.01%	7079
2022 Q4	$1K	Hold	350	–	–	﹤0.01%	6888
2022 Q3	$0	Hold	350	–	–	﹤0.01%	7373
2022 Q2	$1K	Hold	350	–	–	﹤0.01%	7085
2022 Q1	$1K	Buy	+350	New	+$1.3K	﹤0.01%	7054

Other funds holding IMMX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Osaic Holdings's IMMX Position: Q1 2026 in Review

Osaic Holdings opened a new position in Immix Biopharma (IMMX) in Q1 2026: 4,000 shares worth $36.4K. The stake represents ﹤0.01% of the portfolio and ranks #5442 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in IMMX as recently as Q3 2024.

Osaic Holdings first reported a position in IMMX in Q1 2022 and has held it in 11 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

Osaic Holdings held 4,000 shares of Immix Biopharma worth $36.4K as of Q1 2026.
Immix Biopharma was a new Osaic Holdings position in Q1 2026.
Immix Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5442 holding.
Osaic Holdings first reported a position in Immix Biopharma in Q1 2022 and has held it in 11 quarters since.
77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.